scorecardresearch
Add as a preferred source on Google
Monday, February 2, 2026
TopicCovid vaccines

Topic: Covid vaccines

Telangana eyes $25 billion in investments for Next-Gen Life Sciences Policy launched at Davos

The policy builds on Telangana’s manufacturing scale to create a value-led hub for advanced healthcare and pharma R&D and innovation.

Seed funding cancelled & the ghost of ‘Howdy Trump’

The best cartoons of the day, chosen by the editors at ThePrint.

In leg-up to vaccination, SII’s Covovax on CoWin as heterologous booster, to cost Rs 225

Amid rising infection, SII had sought the inclusion of Covovax as a heterologous booster on the CoWin web portal last week.

11% of 69 crore eligible people have taken Covid precaution dose, says govt, blames waning fear

Slight rise in precaution dose coverage after vaccines were made free but govt officials cite ‘Covid surge in many countries’ to emphasise need to increase uptake.

BA.2.75 — new Covid variant detected in India a mystery, but could ‘have immune-escape property’

This Omicron sub-lineage may have increased ability to infect people who’ve been infected before, or are vaccinated, according to some scientists. However, there's no govt data on this.

DCGI approval in, but here’s why you can’t choose Corbevax as your booster just yet

Corbevax was, over the weekend, approved for heterologous use as a Covid booster shot by apex drug regulator Drugs Controller General of India.

Our take on WHO’s Covid deaths estimate, RBI rate hike, SC’s vaccine take — in 50 words

ThePrint view on the most important issues this week.

2nd Covid shot from Serum Institute, Rs 225/dose: All about Covovax, new jab approved for teens

Covovax, developed by US company Novavax & manufactured in India by Serum Institute, is a protein-based vaccine developed from SARS-CoV-2 strain.

The ZyCoV-D mystery: 3 months after arrival in Bihar, not a single Covid vaccine shot given

Covid vaccine developed by Zydus Lifesciences was approved for use in those aged 12 and above in September 2021. Centre ordered 1 crore doses last year & delivery began in February.

We can’t ‘boost’ our way out of the Covid pandemic for the long term

While the vaccine is effective at preventing severe disease, it is likely that boosters will become an annual shot. Here's the science behind it.

On Camera

Floundering PM Internship Scheme has seen 44% drop out since 2024 launch. Budget deals drastic blow

Only 21 percent of interns complete programme as Centre slashes budget by over 50% after poor joining and high attrition.

CDS Gen Chauhan in Armenia, focus on deeper defence ties including new deals

Armenia has procured significant defence equipment from India, including artillery guns, multi-barrel rocket launchers, air defence system, sniper rifles, weapons locating radars, anti-drone weapons.

Swiss report should now close Op Sindoor debate. Knowing when to stop the fight is key too

The key to fighting a war successfully, or even launching it, is a clear objective. That’s an entirely political call. It isn’t emotional or purely military.